Inactive Instrument

Press Releases Sunshine Heart Inc Nasdaq

Equities

US86782U3041

End-of-day quote Nasdaq Other stock markets
- ^USD	-

05-07	Top Midday Gainers	MT
05-07	Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida	05-14	AQ
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy	05-09	AQ
Nuwellis, Inc. Announces First Quarter 2024 Financial Results	05-07	AQ
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	05-02	AQ
Nuwellis Announces Closing of $2.7 Million Public Offering	04-30	AQ
Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024	04-30	AQ
Nuwellis Announces Pricing of $2.7 Million Public Offering	04-26	AQ
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	04-09	AQ
Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference	03-07	AQ
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results	03-05	AQ
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	02-27	AQ
Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™	02-22	AQ
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02-20	AQ
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference	02-20	AQ
New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload	02-06	AQ
Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter	01-04	AQ
New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients	11-28	AQ
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	11-14	AQ
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results	11-07	AQ
Nuwellis Announces Board of Directors Transition	11-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sunshine Heart Inc Nasdaq

Equities

US86782U3041

Press Releases

Filters